» Articles » PMID: 11017079

Nuclear Gene OPA1, Encoding a Mitochondrial Dynamin-related Protein, is Mutated in Dominant Optic Atrophy

Overview
Journal Nat Genet
Specialty Genetics
Date 2000 Oct 4
PMID 11017079
Citations 600
Authors
Affiliations
Soon will be listed here.
Abstract

Optic atrophy type 1 (OPA1, MIM 165500) is a dominantly inherited optic neuropathy occurring in 1 in 50,000 individuals that features progressive loss in visual acuity leading, in many cases, to legal blindness. Phenotypic variations and loss of retinal ganglion cells, as found in Leber hereditary optic neuropathy (LHON), have suggested possible mitochondrial impairment. The OPA1 gene has been localized to 3q28-q29 (refs 13-19). We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria. We found four different OPA1 mutations, including frameshift and missense mutations, to segregate with the disease, demonstrating a role for mitochondria in retinal ganglion cell pathophysiology.

Citing Articles

The Intersection of Mitophagy and Autism Spectrum Disorder: A Systematic Review.

Kovacheva E, Gevezova M, Mehterov N, Kazakova M, Sarafian V Int J Mol Sci. 2025; 26(5).

PMID: 40076836 PMC: 11899999. DOI: 10.3390/ijms26052217.


Creating Optimal Western Blot Conditions for OPA1 Isoforms in Skeletal Muscle Cells and Tissue.

Mungai M, Crabtree A, Le H, Moore J, Nguyen D, Rodriguez B Curr Protoc. 2025; 5(2):e70004.

PMID: 39906927 PMC: 11795335. DOI: 10.1002/cpz1.70004.


Derivation and Characterization of Isogenic Mutant and Control Human Pluripotent Stem Cell Lines.

Pohl K, Zhang X, Ji J, Stiles L, Sadun A, Yang X Cells. 2025; 14(2).

PMID: 39851566 PMC: 11764107. DOI: 10.3390/cells14020137.


A bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots.

Wang L, Yu T, Wang R, Fu L, Dong F, Zhao S Front Med (Lausanne). 2025; 11():1497446.

PMID: 39835089 PMC: 11743512. DOI: 10.3389/fmed.2024.1497446.


Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.